NEPH - Nephros guides Q4 and FY22 revenue slightly below estimates
-
Nephros ( NASDAQ: NEPH ) anticipates Q4 net revenue to be ~$2.6M, a 6% Q/Q increase and a 6% decrease Y/Y, vs consensus of $2.81M .
-
FY22 net revenue is expected to be ~$10.0M, a 2% decrease Y/Y, vs consensus of $10 .29M .
-
The company ended the quarter with ~$3.6M in cash on a consolidated basis.
-
"Nephros certainly faced some headwinds in 2022, but we ended the year on a strong positive note, with sequential revenue growth, record Active Customer Sites (ACS), and significantly improved net cash flow. Quarter-over-quarter revenue increased 6% in the fourth quarter, ACS increased to a new record of 1,394, and our net cash flow for the second half of the year was approximately negative $500,000, compared to negative $2.9 million in the first half," said Andy Astor, President and Chief Executive Officer.
-
For further details see:
Nephros guides Q4 and FY22 revenue slightly below estimates